A Study of Children With Refractory or Relapsed ALL

NCT00187083 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Acute Lymphoblastic Leukemia

Interventions

DRUG: Topotecan, dexamethasone, vincristine
DRUG: E. coli Asparaginase, PEG-L-asparaginase
DRUG: erwinia asparaginase
DRUG: fludarabine, methotrexate, mercaptopurine
DRUG: idarubicin, etoposide, cytarbine, teniposide
PROCEDURE: chemotherapy, intrathecal chemotherapy, steroid therapy

Sponsor

St. Jude Children's Research Hospital